These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 666153)

  • 21. Influence of long-term infusions on lidocaine kinetics.
    Bauer LA; Brown T; Gibaldi M; Hudson L; Nelson S; Raisys V; Shea JP
    Clin Pharmacol Ther; 1982 Apr; 31(4):433-7. PubMed ID: 7060324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients.
    Christians U; Kohlhaw K; Esselmann H; Sürig T; Luy M; Kaltefleiter M; Beyrau R; Linck A; Ringe B; Oellerich M
    Transplant Proc; 1994 Oct; 26(5):2827-8. PubMed ID: 7940891
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dynamic liver function study using the lidocaine test].
    Sídlová K; Průsa R
    Cas Lek Cesk; 2000 Sep; 139(19):604-5. PubMed ID: 11192753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of lidocaine and monoethylglycylxylidide (MEGX) in lidocaine associated deaths.
    Peat MA; Deyman ME; Crouch DJ; Margot P; Finkle BS
    J Forensic Sci; 1985 Oct; 30(4):1048-57. PubMed ID: 4067534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the metabolism of lidocaine. I. The properties of the enzyme system responsible for the oxidative metabolism of lidocaine.
    HOLLUNGER G
    Acta Pharmacol Toxicol (Copenh); 1961; 17():356-64. PubMed ID: 13715410
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
    Chindavijak B; Belpaire FM; Bogaert MG
    Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics and maternal and neonatal effects of epidural lidocaine in preeclampsia.
    Ramanathan J; Bottorff M; Jeter JN; Khalil M; Sibai BM
    Anesth Analg; 1986 Feb; 65(2):120-6. PubMed ID: 3942298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lidocaine pharmacokinetics in children during general anesthesia.
    Finholt DA; Stirt JA; DiFazio CA; Moscicki JC
    Anesth Analg; 1986 Mar; 65(3):279-82. PubMed ID: 3954094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrahepatic metabolism of 4-methylumbelliferone and lidocaine in the anhepatic rabbit.
    Nyberg SL; Mann HJ; Hu MY; Payne WD; Hu WS; Cerra FB; Remmel RP
    Drug Metab Dispos; 1996 Jun; 24(6):643-8. PubMed ID: 8781779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of prolonged recumbency on drug disposition.
    Kates RE; Harapat SR; Keefe DL; Goldwater D; Harrison DC
    Clin Pharmacol Ther; 1980 Nov; 28(5):624-8. PubMed ID: 7438681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. III. Evaluation of liver models for time-dependent behavior.
    Gray MR; Saville BA; Tam YK
    Drug Metab Dispos; 1987; 15(1):22-6. PubMed ID: 2881754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of external cardiopulmonary resuscitation on lidocaine pharmacokinetics in dogs.
    Chow MS; Ronfeld RA; Hamilton RA; Helmink R; Fieldman A
    J Pharmacol Exp Ther; 1983 Mar; 224(3):531-7. PubMed ID: 6827477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of histamine-2 receptor blockade on lidocaine kinetics.
    Jackson JE; Bentley JB; Glass SJ; Fukui T; Gandolfi AJ; Plachetka JR
    Clin Pharmacol Ther; 1985 May; 37(5):544-8. PubMed ID: 3987178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
    Drayer DE; Lorenzo B; Werns S; Reidenberg MM
    Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid effects on lidocaine disposition and toxicity in mice.
    Garty M; Ben-Zvi Z; Hurwitz A
    J Pharmacol Exp Ther; 1985 Aug; 234(2):391-4. PubMed ID: 4020677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.